CLHLF (Coltene Holding AG) ROCE %: 22.93% (As of Dec. 2025)


CLHLF Coltene Holding AG CLHLF
68 GF Score
Price $61.16
GF Value $66.41
! 3 Warning Signs
View Full Analysis

What is Coltene Holding AG ROCE %?

Coltene Holding AG CLHLF 68 ROCE % is 22.93% as of Dec. 2025. GuruFocus rates CLHLF with a GF Score™ of 68/100 and a GF Value™ of $66.41. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Coltene Holding AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 22.93%.

Coltene Holding AG  (OTCPK:CLHLF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Coltene Holding AG ROCE % Related Terms

Coltene Holding AG ROCE % Historical Data

* Premium members only.

The historical data trend for Coltene Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coltene Holding AG ROCE % Chart

Coltene Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.17 28.70 16.08 24.96 18.25

Coltene Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.97 24.66 26.21 15.09 22.93
CLHLF
68GF Score
Coltene Holding AG CLHLF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coltene Holding AG ROCE % Calculation

Coltene Holding AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=23.79/( ( (209.675 - 81.717) + (229.97 - 97.212) )/ 2 )
=23.79/( (127.958+132.758)/ 2 )
=23.79/130.358
=18.25 %

Coltene Holding AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=28.688/( ( (217.927 - 100.478) + (229.97 - 97.212) )/ 2 )
=28.688/( ( 117.449 + 132.758 )/ 2 )
=28.688/125.1035
=22.93 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 22.93% mean?
Coltene Holding AG (CLHLF) has a ROCE % of 22.93% as of Dec. 2025.
Is Coltene Holding AG's ROCE % too high?
Coltene Holding AG's current ROCE % is 22.93%. The Medical Devices & Instruments industry median ROCE % is 2.23. Coltene Holding AG's value of 22.93% is 928.3% above this industry median. Overall, Coltene Holding AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's ROCE % compare to ISRG and BDX?
Coltene Holding AG's ROCE % of 22.93% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Coltene Holding AG's value of 22.93% is 928.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coltene Holding AG's current ROCE % of 22.93% is 928.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current ROCE % is 22.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Coltene Holding AG (CLHLF) has a current ROCE % of 22.93%. The stock's GF Value™ is $66.41, compared to a current price of $61.16 — trading 7.9% below its estimated fair value. The current ROCE % is 22.93% and 928.3% above the Medical Devices & Instruments industry median of 2.23. Coltene Holding AG's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Coltene Holding AG (CLHLF), the current ROCE % is 22.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coltene Holding AG (CLHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued. The current stock price of $61.16 is trading 7.9% below its estimated GF Value™ of $66.41.

Key valuation signals for CLHLF:

  • ROCE %: 22.93%
  • GF Value™: $66.41 vs. price of $61.16 (7.9% below fair value)
  • GF Score™: 68/100 with 3 warning signs
  • Industry Position: 928.3% above the Medical Devices & Instruments median

No single metric tells the full story. See the CLHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coltene Holding AG Business Description

Address Feldwiesenstrasse 20, Altstatten, CHE, 9450
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
68GF Score

Get the complete analysis for CLHLF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$61.16
Price
$66.41
GF Value